Giving women the human papillomavirus (HPV) vaccine around the time they have surgery for precancerous cervical lesions might lead to a reduction in the risk of lesions returning as well as other HPV-related diseases, suggests a study published by The BMJ today.
You may also be interested in:
A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and [...]
It’s not the mobile that makes children hyperactive, but the other way round: a fidgety child will use a mobile phone more—according to the latest [...]
A lifeguard shortage in many parts of the U.S. means an increased drowning risk at pools and beaches this summer. Earlier this summer, SciLine interviewed [...]